{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:48:33Z","timestamp":1791460113486,"version":"4.3.4"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"am","delay-in-days":341,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23EY027849"],"award-info":[{"award-number":["K23EY027849"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.contraception.2023.110089","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T04:46:21Z","timestamp":1686890781000},"page":"110089","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Levonorgestrel intrauterine device use and incident idiopathic intracranial hypertension among commercially\u00a0insured women"],"prefix":"10.1016","volume":"125","author":[{"given":"Lindsey B.","family":"De Lott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle H.","family":"Moniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie M.","family":"Niziol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeeta","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Musch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne T.","family":"Cornblath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2023.110089_bib1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1177\/2042098615588084","article-title":"Risk of intracranial hypertension with intrauterine levonorgestrel","volume":"6","author":"Etminan","year":"2015","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.contraception.2023.110089_bib2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/01658107.2017.1304425","article-title":"An estimation of the risk of pseudotumor cerebri among users of the levonorgestrel intrauterine device","volume":"41","author":"Valenzuela","year":"2017","journal-title":"Neuroophthalmology"},{"key":"10.1016\/j.contraception.2023.110089_bib3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/2042098615622316","article-title":"Risk of intracranial hypertension with intrauterine levonorgestrel","volume":"7","author":"Friedman","year":"2016","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.contraception.2023.110089_bib4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ajo.2018.09.014","article-title":"A population-based, case-control evaluation of the association between hormonal contraceptives and idiopathic intracranial hypertension","volume":"197","author":"Kilgore","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.contraception.2023.110089_bib5","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1212\/WNL.0b013e3182a55f17","article-title":"Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children","volume":"81","author":"Friedman","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.contraception.2023.110089_bib6","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.contraception.2023.110089_bib7","first-page":"756","article-title":"Association between cardiometabolic risk factors and body mass index based on diagnosis and treatment codes in an electronic medical record database","volume":"14","author":"Brixner","year":"2008","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.contraception.2023.110089_bib8","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.contraception.2012.07.018","article-title":"Levonorgestrel-releasing intrauterine system for heavy menstrual bleeding improves hemoglobin and ferritin levels","volume":"86","author":"Kaunitz","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2023.110089_bib9","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1056\/NEJMoa1204724","article-title":"Levonorgestrel intrauterine system versus medical therapy for menorrhagia","volume":"368","author":"Gupta","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2023.110089_bib10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/13625187.2014.894184","article-title":"Impact of a new levonorgestrel intrauterine system, Levosert \u00ae, on heavy menstrual bleeding: results of a one-year randomised controlled trial","volume":"19","author":"Mawet","year":"2014","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"5","key":"10.1016\/j.contraception.2023.110089_bib11","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/humupd\/dmv023","article-title":"Non-contraceptive benefits of hormonal and intrauterine reversible contraceptive methods","volume":"21","author":"Bahamondes","year":"2015","journal-title":"Hum Reprod Update"},{"issue":"6","key":"10.1016\/j.contraception.2023.110089_bib12","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.soard.2015.08.497","article-title":"Bariatric surgery as a treatment for idiopathic intracranial hypertension: a systematic review","volume":"11","author":"Handley","year":"2015","journal-title":"Surg Obes Relat Dis"},{"issue":"4","key":"10.1016\/j.contraception.2023.110089_bib13","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ajo.2006.12.040","article-title":"Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri)","volume":"143","author":"Daniels","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.contraception.2023.110089_bib14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.contraception.2012.01.015","article-title":"Quantitative levonorgestrel plasma level measurements in patients with regular and prolonged use of the levonorgestrel-releasing intrauterine system","volume":"86","author":"Seeber","year":"2012","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.contraception.2023.110089_bib15","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.contraception.2017.11.007","article-title":"Obesity and contraceptive use among women 20-44 years of age in the United States: results from the 2011-15 National Survey of Family Growth (NSFG)","volume":"97","author":"Mosher","year":"2018","journal-title":"Contraception."},{"key":"10.1016\/j.contraception.2023.110089_bib16","first-page":"1","article-title":"Prevalence of obesity and severe obesity among adults: United States, 2017\u20132018","volume":"360","author":"Hales","year":"2020","journal-title":"NCHS Data Brief"},{"issue":"1","key":"10.1016\/j.contraception.2023.110089_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/IIO.0b013e3182aabf11","article-title":"Epidemiology and risk factors for idiopathic intracranial hypertension","volume":"54","author":"Chen","year":"2014","journal-title":"Int Ophthalmol Clin"},{"issue":"1","key":"10.1016\/j.contraception.2023.110089_bib18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/2042098615621264","article-title":"Risk of intracranial hypertension with intrauterine levonorgestrel: reply","volume":"7","author":"Etminan","year":"2016","journal-title":"Ther Adv Drug Saf"},{"issue":"10","key":"10.1016\/j.contraception.2023.110089_bib19","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/2042098617709768","article-title":"Revised disproportionality analysis of Mirena and benign intracranial hypertension","volume":"8","author":"Etminan","year":"2017","journal-title":"Ther Adv Drug Saf"},{"issue":"2","key":"10.1016\/j.contraception.2023.110089_bib20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/01658107.2018.1465439","article-title":"An estimation of the risk of pseudotumor cerebri among users of the levonorgestrel intrauterine device","volume":"43","author":"Golozar","year":"2019","journal-title":"Neuro-ophthalmology"},{"key":"10.1016\/j.contraception.2023.110089_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.conx.2021.100060","article-title":"Use of concurrent multiple methods of contraception in the United States, 2008 to 2015","volume":"3","author":"Kavanaugh","year":"2021","journal-title":"Contraception X"},{"issue":"5","key":"10.1016\/j.contraception.2023.110089_bib22","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1212\/WNL.34.6.721","article-title":"Pseudoturnor cerebri and pregnancy","volume":"34","author":"Digre","year":"1984","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.contraception.2023.110089_bib23","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/01.mlr.0000132391.59713.0d","article-title":"Validity of procedure codes in International Classification of Diseases, 9th Revision, Clinical Modification Administrative Data","volume":"42","author":"Quan","year":"2004","journal-title":"Med Care"},{"issue":"3","key":"10.1016\/j.contraception.2023.110089_bib24","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/WNO.0000000000001373","article-title":"Should lumbar puncture be required to diagnose every patient with idiopathic intracranial hypertension","volume":"41","author":"Moss","year":"2021","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.contraception.2023.110089_bib25","unstructured":"Intrauterine Devices (IUDs): Access for Women in the U.S. Kaiser Family Foundation [September 9, 2020] https:\/\/www.kff.org\/womens-health-policy\/fact-sheet\/intrauterine-devices-iuds-access-for-women-in-the-u-s\/\u00a0(accessed June 1, 2023)."}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782423001737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782423001737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T21:12:24Z","timestamp":1762117944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782423001737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":25,"alternative-id":["S0010782423001737"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2023.110089","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levonorgestrel intrauterine device use and incident idiopathic intracranial hypertension among commercially\u00a0insured women","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2023.110089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110089"}}